These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6627241)

  • 41. [Ifosfamide in pediatric malignancy--experiences in the Northern Israel Oncology Center].
    Roguin A; Ben Arush MW; Higasi A; Kuten A
    Harefuah; 1996 Apr; 130(8):511-4, 584. PubMed ID: 8765870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Salvage chemotherapy with a combination of VP-16, ifosfamide, procarbazine, prednisolone, bleomycin and methotrexate (VIPP-BM) for refractory malignant lymphoma].
    Ohnishi K; Hotta T; Murate T; Inoue C; Ichikawa A; Ninomiya N; Goto S; Tsushita K; Utsumi M; Nagura E
    Rinsho Ketsueki; 1989 Mar; 30(3):289-96. PubMed ID: 2475652
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Ifosfamide in the treatment of small cell carcinoma of the lung].
    Mukouda K; Morikawa E; Hasegawa K; Noumi K; Ohmura T; Mishima Y; Kawamoto M; Inagaki A; Kamitsuna A; Yamakido M; Nishimoto Y; Koyama T; Katsuta S
    Gan To Kagaku Ryoho; 1983 May; 10(5):1293-8. PubMed ID: 6307164
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The use of holoxan (iphosphamide) in malignant tumors].
    Perevodchikova NI; Orel NF; Trofimova NV
    Vopr Onkol; 1990; 36(9):1085-8. PubMed ID: 2122594
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ifosfamide in combination chemotherapy for sarcomas and testicular carcinomas.
    Niederle N; Scheulen ME; Cremer M; Schütte J; Schmidt CG; Seeber S
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():129-35. PubMed ID: 6627239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of ifosfamide toxicity using dose fractionation.
    Rodriguez V; Bodey GP; Freireich EJ; McCredie KB; McKelvey EM; Tashima CK
    Cancer Res; 1976 Aug; 36(8):2945-8. PubMed ID: 1277203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ifosfamide-based chemotherapy for non-small cell lung cancer: phase I/II studies at the University of Chicago.
    Vokes EE; Hoffman PC; Masters GA; Golomb HM; Drinkard LC; Krauss SA
    Semin Oncol; 1996 Jun; 23(3 Suppl 7):15-8. PubMed ID: 8711496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ifosfamide in the treatment of breast cancer.
    Overmoyer BA
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):38-41. PubMed ID: 8677447
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Phase I trial of ifosfamide and paclitaxel with granulocyte-colony stimulating factor in the treatment of patients with refractory solid tumors.
    Bunnell CA; Thompson L; Buswell L; Berkowitz R; Muto M; Sheets E; Shulman LN
    Cancer; 1998 Feb; 82(3):561-6. PubMed ID: 9452275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
    Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
    Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute pancreatitis after ifosfamide therapy.
    Izraeli S; Adamson PC; Blaney SM; Balis FM
    Cancer; 1994 Sep; 74(5):1627-8. PubMed ID: 8062195
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Reactivation of prostatic cancer and chemotherapy in reactivated prostatic cancer].
    Fuse H; Ando K; Hara S; Zama S; Shimazaki J
    Hinyokika Kiyo; 1985 Feb; 31(2):281-7. PubMed ID: 2409787
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Manic episode in an ifosfamide-treated patient.
    Brieger P; Marneros A; Wolf HH; Schmoll HJ
    Gen Hosp Psychiatry; 2000; 22(1):52-3. PubMed ID: 10766557
    [No Abstract]   [Full Text] [Related]  

  • 54. Single-dose ifosfamide: efficacy studies in non-small cell lung cancer.
    Harrison EF; Hawke JE; Hunter HL; Costanzi JJ; Morgan LR; Plotkin D; Tucker WG; Worrall PM
    Semin Oncol; 1982 Dec; 9(4 Suppl 1):56-60. PubMed ID: 6298944
    [No Abstract]   [Full Text] [Related]  

  • 55. Current studies of ifosfamide for pediatric solid tumors and leukemia in the United States.
    Pratt CB
    Semin Oncol; 1992 Dec; 19(6 Suppl 12):43-9. PubMed ID: 1485174
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.
    Morgan LR; Posey LE; Rainey J; Bickers J; Ryan D; Vial R; Hull EW
    Cancer Treat Rep; 1981; 65(7-8):693-5. PubMed ID: 6265084
    [No Abstract]   [Full Text] [Related]  

  • 57. Ifosfamide in non-small cell lung cancer: a review.
    Eberhardt W; Niederle N
    Semin Oncol; 1992 Feb; 19(1 Suppl 1):40-8. PubMed ID: 1329211
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pilot study of intravenous ifosfamide plus oral acetylcysteine in the treatment of non-small cell lung cancer.
    Saiers JH; Slavik M
    Vet Hum Toxicol; 1981; 23(Suppl 1):12-4. PubMed ID: 6272470
    [No Abstract]   [Full Text] [Related]  

  • 59. New drug found active against lung cancers.
    Hospitals; 1982 Jun; 56(12):38. PubMed ID: 7042515
    [No Abstract]   [Full Text] [Related]  

  • 60. Experience with ifosfamide and etoposide combination chemotherapy in extensive-disease small-cell lung cancer.
    Wu MF; Perng RP; Chen YM; Liu JM; Yang SL; Whang-Peng J
    Zhonghua Yi Xue Za Zhi (Taipei); 1997 Aug; 60(2):67-73. PubMed ID: 9360330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.